Mantomed (Memantine Hydrochloride)

Memantine hydrochloride acts as a non‑competitive antagonist at the NMDA receptor. By blocking excessive calcium influx caused by overstimulation with glutamate, it reduces excitotoxicity while allowing normal neurotransmission, which supports neuronal survival in Alzheimer’s disease.

The dosage of Mantomed is individualized by the prescribing clinician based on the patient’s condition, renal function, and tolerability. No fixed regimen is provided here; the prescriber determines the appropriate dose and titration schedule.

Safety data for memantine during pregnancy and lactation are limited, and the product is classified as having an unknown pregnancy category. Use only if the potential benefit justifies the potential risk to the fetus or infant, and discuss with a healthcare professional.

To request Mantomed, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

The primary alternative class for Alzheimer’s disease is acetylcholinesterase inhibitors such as donepezil. While those agents increase acetylcholine levels, memantine (Mantomed) modulates glutamate activity. Both can be used together for complementary effects, but their mechanisms, side‑effect profiles, and contraindications differ.

Mantomed tablets should be stored at ambient temperature, below 25 °C, in the original container to protect from moisture and light. Keep out of reach of children and do not use after the expiry date printed on the packaging.

Mantomed is taken orally, usually once daily after a gradual titration period as directed by the prescriber. Tablets should be swallowed whole with water and not crushed or chewed unless specifically instructed.

Serious risks include the possibility of seizures, cardiac arrhythmias, and severe allergic reactions such as anaphylaxis. Patients should seek immediate medical attention if they experience unexplained convulsions, irregular heartbeats, or signs of a severe hypersensitivity reaction.

Mantomed is contraindicated in patients with known hypersensitivity to memantine or any tablet excipients. Caution is advised for individuals with uncontrolled seizures, severe renal or hepatic impairment, and those taking other NMDA antagonists. Pregnant or breastfeeding women should only use it when clearly indicated by a physician.